Skip to main content
Metal-Based Drugs logoLink to Metal-Based Drugs
. 1998;5(2):83–90. doi: 10.1155/MBD.1998.83

Toxicity Profiles In Vivo in Mice and Antitumour Activity in Tumour-Bearing Mice of Di- and Triorganotin Compounds

M Gielen 1,✉, R Willem 1,2, H Dalil 1, D de Vos 3, C M Kuiper 4, G J Peters 4
PMCID: PMC2365102  PMID: 18475827

Abstract

The in vivo toxicity profiles in mice and the antitumour activity in tumour bearing mice were screened for four di-n-butyltin and five triorganotin carboxylates, di-n-butyltin diterebate (5), bis(phenylacetate) (6), bis(deoxycholate) (7), bis(lithocholate) (8), tri-n-butyltin terebate (9), cinnamate (10), and triphenyltin terebate (11).

At their maximum tolerated dosis (MTD), no antitumour effect (T/C ~1) was observed for the compounds 5, 7, 9, 10 and 11. The compounds 6 (T/C = 0.51) and 8 (T/C = 0.42) showed clear antitumour activity after single dose administration and might therefore be of interest for further antitumour activity studies.

Full Text

The Full Text of this article is available as a PDF (768.7 KB).


Articles from Metal-Based Drugs are provided here courtesy of Wiley

RESOURCES